Retina Today

Retina Today Bringing you the latest research, clinical developments, and industry insights in surgical and medic A BMC Vision publication.

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.

Did you miss the AAO lectures and panels on surgical approaches to DR/DME, scleral buckling, imaging in the OR, and surg...
11/15/2025

Did you miss the AAO lectures and panels on surgical approaches to DR/DME, scleral buckling, imaging in the OR, and surgical innovations? Our Eyetube video meeting coverage has your summaries: https://ow.ly/mbF050XqO9c

New data, big implications: Automated insulin delivery ( ) continues to show a strong safety profile for patients with d...
11/14/2025

New data, big implications: Automated insulin delivery ( ) continues to show a strong safety profile for patients with diabetic retinopathy— with the majority maintaining stable or even improved retinal status.

This emerging evidence could reshape how we counsel and manage our T1D patients who rely on advanced glucose technology.

Dive into the full analysis and what it means for retina care from Francesc March de Ribot, MD, PhD and Ben Wheeler, MD, PhD here: https://ow.ly/WJnY50XrLuz

11/13/2025

🧠 Mindset shift: from restoring vision to preserving tissue. Hear why that framing helps improve communication with GA patients. https://ow.ly/4g9q50XqbGY

🔬 What’s next in dry AMD and Stargardt disease? From oral tablets to gene therapy to complement inhibition, talks at   p...
11/11/2025

🔬 What’s next in dry AMD and Stargardt disease?

From oral tablets to gene therapy to complement inhibition, talks at provided a robust update. Join Drs. Peter Kaiser and Michel Michaelides as they break down the latest breakthroughs in research.

🎧 Listen now: https://ow.ly/y8rL50Xq2yM

The 50th Annual ACRC and Macula 2026 meeting is heading to Philly, January 8-10! Register ‼️TODAY‼️ to take advantage of...
11/10/2025

The 50th Annual ACRC and Macula 2026 meeting is heading to Philly, January 8-10! Register ‼️TODAY‼️ to take advantage of early-bird pricing for Macula 2026! https://ow.ly/sCfE50XpxCy

Wills Eye Hospital, Mid Atlantic Retina, Penn Medicine

Exclusively available from Bausch + Lomb, the Cohen-Benner Surgical Contact Lens brings clarity and stability to your su...
11/07/2025

Exclusively available from Bausch + Lomb, the Cohen-Benner Surgical Contact Lens brings clarity and stability to your surgical experience with excellent visualization of the macula. Lens on. Hands off. Learn more at https://ow.ly/I63m50WanrA

11/06/2025

Residents and retina fellows stepped to the podium to share important data at AAO! Head to Eyetube to hear them summarize their presentations. https://ow.ly/kScq50XmwBe

📊 Track the full pipeline of DR/DME therapies in an easy-to-navigate format. Approved drugs and next-gen science—all org...
11/05/2025

📊 Track the full pipeline of DR/DME therapies in an easy-to-navigate format. Approved drugs and next-gen science—all organized by route of administration. https://ow.ly/EtSh50XnkW1

LESS THAN 1 MONTH TO FLORetina-ICOOR 2025 — from market and regulatory strategy to scientific and clinical discoveryJoin...
11/04/2025

LESS THAN 1 MONTH TO FLORetina-ICOOR 2025 — from market and regulatory strategy to scientific and clinical discovery

Join us in Florence this December for FLORetina-ICOOR 2025, one of the premier European congress in ophthalmology. This year’s edition features two groundbreaking back-to-back programs:

🔹 EYENOVATE (December 3–4): A dynamic pre-congress event dedicated to innovation, investment, and regulatory strategy in eye care. EYENOVATE brings together startups, industry leaders, investors, and regulators to shape the future of ophthalmic innovation.

🔹 Retina Futura (4 sessions throughout the Congress program): A visionary platform spotlighting emerging science and patient-centered approaches in retinal care. Retina Futura fosters dialogue between clinicians, researchers and regulators to accelerate meaningful change.

Be part of the conversation that’s redefining the future of retina.

🌐 Learn more on EYENOVATE and register: [www.eyenovate.org]

🌐 Learn more on the Retina Futura sessions: [www.retinafutura.com]

What happens when a patient with intermediate AMD returns with wet AMD and a massive PED? And after switching anti-VEGF ...
11/04/2025

What happens when a patient with intermediate AMD returns with wet AMD and a massive PED? And after switching anti-VEGF agents, how do you account for vision loss despite resolution of exudative activity? Dr. Yasha Modi shares a case with specialists Drs. Joe Coney and Priya Vakharia: https://ow.ly/IMyo50Xm6QQ

📽️ Need some real-world GA cases to see how your colleagues are practicing? Join Drs. Kitchens, Eichenbaum, Chang, and A...
10/31/2025

📽️ Need some real-world GA cases to see how your colleagues are practicing?

Join Drs. Kitchens, Eichenbaum, Chang, and Ali as they use cases as a launch point for discussing dynamics in GA treatment: https://ow.ly/YFHN50Xlb0s

PVR remains one of the greatest challenges in retinal surgery — testing even the most experienced surgeons.In this Retin...
10/29/2025

PVR remains one of the greatest challenges in retinal surgery — testing even the most experienced surgeons.

In this Retina Today feature, Sidra Zafar, MD, and Jason Hsu, MD, explore how preparation, precision, and persistence can transform surgical chaos into control. From meticulous preoperative planning to real-time adaptability in the OR, these insights shed light on how to truly “tame the beast.”

👉 Read the full article: https://ow.ly/CBcU50Xk0Bz

Address

1008 Upper Gulph Road
Wayne, PA
19087

Alerts

Be the first to know and let us send you an email when Retina Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share